JP2015522547A5 - - Google Patents

Download PDF

Info

Publication number
JP2015522547A5
JP2015522547A5 JP2015513234A JP2015513234A JP2015522547A5 JP 2015522547 A5 JP2015522547 A5 JP 2015522547A5 JP 2015513234 A JP2015513234 A JP 2015513234A JP 2015513234 A JP2015513234 A JP 2015513234A JP 2015522547 A5 JP2015522547 A5 JP 2015522547A5
Authority
JP
Japan
Prior art keywords
dihydroxy
alkyl
isophthalonitrile
dihydroxyisophthalonitrile
aryl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2015513234A
Other languages
English (en)
Japanese (ja)
Other versions
JP2015522547A (ja
JP6181747B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/FI2013/000026 external-priority patent/WO2013175053A1/en
Publication of JP2015522547A publication Critical patent/JP2015522547A/ja
Publication of JP2015522547A5 publication Critical patent/JP2015522547A5/ja
Application granted granted Critical
Publication of JP6181747B2 publication Critical patent/JP6181747B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2015513234A 2012-05-24 2013-05-23 カテコールo−メチルトランスフェラーゼ活性阻害化合物 Expired - Fee Related JP6181747B2 (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US201261651217P 2012-05-24 2012-05-24
US61/651,217 2012-05-24
US201361777162P 2013-03-12 2013-03-12
US61/777,162 2013-03-12
PCT/FI2013/000026 WO2013175053A1 (en) 2012-05-24 2013-05-23 Catechol o-methyltransferase activity inhibiting compounds

Publications (3)

Publication Number Publication Date
JP2015522547A JP2015522547A (ja) 2015-08-06
JP2015522547A5 true JP2015522547A5 (enExample) 2016-06-09
JP6181747B2 JP6181747B2 (ja) 2017-08-16

Family

ID=48669995

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2015513234A Expired - Fee Related JP6181747B2 (ja) 2012-05-24 2013-05-23 カテコールo−メチルトランスフェラーゼ活性阻害化合物

Country Status (34)

Country Link
US (6) US9458128B2 (enExample)
EP (1) EP2855426B1 (enExample)
JP (1) JP6181747B2 (enExample)
KR (1) KR102100612B1 (enExample)
CN (1) CN104334525B (enExample)
AR (1) AR091144A1 (enExample)
AU (1) AU2013265119B2 (enExample)
BR (1) BR112014029139B1 (enExample)
CA (1) CA2871801C (enExample)
CL (1) CL2014003191A1 (enExample)
CO (1) CO7151502A2 (enExample)
CY (1) CY1118740T1 (enExample)
DK (1) DK2855426T3 (enExample)
EA (1) EA028466B1 (enExample)
ES (1) ES2613692T3 (enExample)
HR (1) HRP20170487T1 (enExample)
HU (1) HUE031366T2 (enExample)
IL (1) IL235396A (enExample)
LT (1) LT2855426T (enExample)
MD (1) MD4556C1 (enExample)
MX (1) MX357896B (enExample)
MY (1) MY168539A (enExample)
NZ (1) NZ701982A (enExample)
PE (1) PE20150024A1 (enExample)
PH (1) PH12014502588B1 (enExample)
PL (1) PL2855426T3 (enExample)
PT (1) PT2855426T (enExample)
RS (1) RS55840B1 (enExample)
SG (1) SG11201407037UA (enExample)
SI (1) SI2855426T1 (enExample)
TN (1) TN2014000474A1 (enExample)
TW (1) TWI638802B (enExample)
WO (1) WO2013175053A1 (enExample)
ZA (1) ZA201408215B (enExample)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SI2861566T1 (sl) 2012-06-13 2017-03-31 F. Hoffmann-La Roche Ag Novi diazaspirocikloalkan in azaspirocikloalkan
PL2900669T3 (pl) 2012-09-25 2020-01-31 F. Hoffmann-La Roche Ag Pochodne heksahydropirolo[3,4-C]pirolu i związki pokrewne jako inhibitory autotaksyny (ATX) oraz inhibitory produkcji kwasu lizofosfatydowego (LPA) do leczenia np. chorób nerek
AR095079A1 (es) 2013-03-12 2015-09-16 Hoffmann La Roche Derivados de octahidro-pirrolo[3,4-c]-pirrol y piridina-fenilo
AU2014356583B2 (en) 2013-11-26 2019-02-28 F. Hoffmann-La Roche Ag New octahydro-cyclobuta (1,2-c;3,4-c')dipyrrol-2-yl
MA50635A (fr) 2014-03-26 2020-08-12 Hoffmann La Roche Nouveaux composés bicycliques comme inhibiteurs de la production d'autotaxin (atx) et de l'acide lysophosphatidique
CR20160418A (es) 2014-03-26 2016-11-07 Hoffmann La Roche Nuevos compuestos biciclicos de 7 eslabones
MA41898A (fr) 2015-04-10 2018-02-13 Hoffmann La Roche Dérivés de quinazolinone bicyclique
EP3344619B1 (en) 2015-09-04 2020-10-28 H. Hoffnabb-La Roche Ag Phenoxymethyl derivatives
WO2017050747A1 (en) 2015-09-24 2017-03-30 F. Hoffmann-La Roche Ag New bicyclic compounds as dual atx/ca inhibitors
MA42918A (fr) 2015-09-24 2018-08-01 Hoffmann La Roche Composés bicycliques utilisés en tant qu'inhibiteurs d'atx
BR112018006080A2 (pt) 2015-09-24 2018-10-09 F. Hoffmann-La Roche Ag novos compostos bicíclicos como inibidores de dupla ação de atx/ca
AU2016328437A1 (en) 2015-09-24 2018-01-25 F. Hoffmann-La Roche Ag Bicyclic compounds as ATX inhibitors
RU2019132254A (ru) 2017-03-16 2021-04-16 Ф. Хоффманн-Ля Рош Аг Гетероциклические соединения, пригодные в качестве дуальных ингибиторов atx/ca
EP3596060B1 (en) 2017-03-16 2023-09-20 F. Hoffmann-La Roche AG New bicyclic compounds as atx inhibitors
WO2019097120A1 (en) 2017-11-16 2019-05-23 Orion Corporation New use and pharmaceutical dosage forms
US20210347728A1 (en) * 2018-07-25 2021-11-11 Orion Corporation 4,5-dihydroxy-2-(4-methylbenzyl)isophthalonitrile solvates and crystalline forms thereof
JP2022506697A (ja) * 2018-11-09 2022-01-17 オリオン コーポレーション 4,5-ジヒドロキシ-2-(4-メチルベンジル)イソフタロニトリルの製造方法
WO2020225398A1 (en) * 2019-05-09 2020-11-12 Merck Patent Gmbh Aromatic compounds
CN110632211A (zh) * 2019-10-18 2019-12-31 上海明捷医药科技有限公司 一种测定药物中2-巯基苯并噻唑迁移量的方法
CN112645971B (zh) * 2021-01-20 2021-12-24 中国科学院兰州化学物理研究所 一种烷基卤代物直接制备烷基硼酸酯类化合物的方法

Family Cites Families (51)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5035393A (enExample) 1973-08-01 1975-04-04
ZA871564B (en) * 1986-03-11 1987-10-28 Hoffmann La Roche 3,5-disubstituted pyrocatechole derivatives
DK175069B1 (da) * 1986-03-11 2004-05-24 Hoffmann La Roche Pyrocatecholderivater
US5236952A (en) 1986-03-11 1993-08-17 Hoffmann-La Roche Inc. Catechol derivatives
US5283352A (en) * 1986-11-28 1994-02-01 Orion-Yhtyma Oy Pharmacologically active compounds, methods for the preparation thereof and compositions containing the same
YU213587A (en) * 1986-11-28 1989-06-30 Orion Yhtymae Oy Process for obtaining new pharmacologic active cateholic derivatives
DE4240321A1 (de) 1992-12-01 1994-06-09 Basf Ag Verfahren zur Herstellung von aromatischen Vinylverbindungen
DE4421730C1 (de) 1994-06-22 1995-11-23 Hoechst Ag Verfahren zur Herstellung von aromatischen Olefinen unter Katalyse von Palladacyclen
GB9510481D0 (en) * 1995-05-24 1995-07-19 Orion Yhtymae Oy New catechol derivatives
DE19647582A1 (de) 1996-11-18 1998-05-20 Hoechst Ag Verfahren zur Herstellung von aromatischen Olefinen mittels Katalyse durch Palladaphosphacyclobutane
GB9626472D0 (en) * 1996-12-20 1997-02-05 Aperia Anita C New use of comt inhibitors
DE19825454A1 (de) 1998-06-06 1999-12-16 Aventis Res & Tech Gmbh & Co Verfahren zur Herstellung von aromatischen Olefinen unter Katalyse von Palladiumkatalysatoren mit Phosphitliganden
US6215035B1 (en) 1998-09-25 2001-04-10 Council Of Scientific And Industrial Research Process for the preparation of aralkylated aromatic compounds using heterogeneous catalyst
GB2344819A (en) 1998-12-18 2000-06-21 Portela & Ca Sa 2-Phenyl-1-(3,4-dihydroxy-5-nitrophenyl)-1-ethanones
FI20000635A0 (fi) * 2000-03-17 2000-03-17 Orion Yhtymae Oyj COMT-inhibiittoreiden käyttö analgeettina
GB0015228D0 (en) 2000-06-21 2000-08-16 Portela & Ca Sa Substituted nitrated catechols, their use in the treatment of some central and peripheral nervous system disorders
GB2363792A (en) 2000-06-21 2002-01-09 Portela & Ca Sa Nitrocatechols
FI20001593A7 (fi) 2000-07-03 2002-01-04 Orion Yhtymo Oyj Comt-entsyymiõ inhiboivaa aktiivisuutta omaavia kumariinijohdannaisia
FI20002044A0 (fi) 2000-09-15 2000-09-15 Orion Yhtymae Oyj Comt-entsyymiä estäviä naftaleenijohdannaisia
US6548722B1 (en) 2000-10-10 2003-04-15 Council Of Scientific And Industrial Research Process for the preparation of substituted aromatic compound employing friedel-crafts reaction using a reusable basic anionic clay catalyst
AU2003205630A1 (en) 2002-01-18 2003-07-30 The Genetics Company Inc. Beta-secretase inhibitors
CA2528538A1 (en) 2003-06-19 2004-12-29 Psychiatric Genomics, Inc. Dual function compounds and uses thereof
WO2005058228A2 (en) 2003-12-19 2005-06-30 F. Hoffmann-La Roche Ag Comt inhibitors
US20060173074A1 (en) * 2004-11-10 2006-08-03 Juha Ellmen Treatment of restless legs syndrome
MY148644A (en) 2005-07-18 2013-05-15 Orion Corp New pharmaceutical compounds
WO2007013830A1 (en) 2005-07-26 2007-02-01 Portela & Ca. S.A. Nitrocatechol derivatives as comt inhibitors
WO2007038215A1 (en) * 2005-09-22 2007-04-05 Incyte Corporation Tetracyclic inhibitors of janus kinases
EP1942732A2 (en) 2005-11-02 2008-07-16 Cytokinetics, Inc. Certain chemical entities, compositions, and methods
WO2007063789A1 (ja) 2005-11-29 2007-06-07 Kissei Pharmaceutical Co., Ltd. 新規なカテコール誘導体、それを含有する医薬組成物およびそれらの用途
US20100048713A1 (en) 2006-01-06 2010-02-25 Aarhus Universitet Compounds acting on the serotonin transporter
EP1845097A1 (en) 2006-04-10 2007-10-17 Portela & Ca., S.A. Oxadiazole derivatives as COMT inhibitors
WO2008024963A1 (en) 2006-08-24 2008-02-28 Serenex, Inc. Benzene, pyridine, and pyridazine derivatives
CA2668744C (en) 2006-11-17 2015-09-15 Queen's University At Kingston Compounds and methods for treating protein folding disorders
JP2008308494A (ja) 2007-05-17 2008-12-25 Kissei Pharmaceut Co Ltd 新規なカテコール誘導体、それを含有する医薬組成物およびそれらの用途
JP2008308495A (ja) 2007-05-17 2008-12-25 Kissei Pharmaceut Co Ltd 新規なカテコール誘導体、それを含有する医薬組成物およびそれらの用途
JP2008308493A (ja) 2007-05-17 2008-12-25 Kissei Pharmaceut Co Ltd 新規なカテコール誘導体、それを含有する医薬組成物およびそれらの用途
JP5279728B2 (ja) 2007-12-25 2013-09-04 キッセイ薬品工業株式会社 新規なカテコール誘導体
JP5369000B2 (ja) 2007-12-25 2013-12-18 キッセイ薬品工業株式会社 新規なカテコール誘導体、それを含有する医薬組成物およびそれらの用途
EP2305633B1 (en) 2008-07-04 2013-03-20 Kissei Pharmaceutical Co., Ltd. Catechol derivative and its use
AU2009274571A1 (en) 2008-07-23 2010-01-28 Massachusetts Institute Of Technology Activation of histone deacetylase 1 (HDAC1) protects against DNA damage and increases neuronal survival
US10532034B2 (en) 2009-03-25 2020-01-14 Cornell University Inhibition of glutaminase C
JP5707063B2 (ja) 2009-06-18 2015-04-22 キッセイ薬品工業株式会社 新規なカテコール誘導体、それを含有する医薬組成物およびそれらの用途
CN101643465A (zh) 2009-08-14 2010-02-10 东华大学 一种comt抑制剂5,6,7,3',4'-五甲氧基异黄酮的制备方法
US9309199B2 (en) 2010-03-04 2016-04-12 Merck Sharp & Dohme Corp. Inhibitors of catechol O-methyl transferase and their use in the treatment of psychotic disorders
CA2789475C (en) 2010-03-04 2018-05-29 Merck Sharp & Dohme Corp. Inhibitors of catechol o-methyl transferase and their use in the treatment of psychotic disorders
JP5995728B2 (ja) 2010-03-04 2016-09-21 メルク・シャープ・エンド・ドーム・コーポレイション カテコールo−メチルトランスフェラーゼの阻害剤および精神障害の治療におけるその使用
JP5883590B2 (ja) 2010-08-06 2016-03-15 キッセイ薬品工業株式会社 新規なカテコール誘導体、それを含有する医薬組成物およびそれらの用途
JP5883591B2 (ja) 2010-08-06 2016-03-15 キッセイ薬品工業株式会社 新規なカテコール誘導体、それを含有する医薬組成物およびそれらの用途
EP2655334B1 (en) 2010-12-22 2018-10-03 Eutropics Pharmaceuticals, Inc. Compositions and methods useful for treating diseases
GB201107176D0 (en) 2011-04-28 2011-06-15 Cxr Biosciences Ltd Pyrrolnitrin derivatives
CN102755312A (zh) 2012-07-16 2012-10-31 中国科学院大连化学物理研究所 具有黄酮骨架结构的化合物作为帕金森症治疗药物的应用

Similar Documents

Publication Publication Date Title
HRP20170487T1 (hr) Spojevi koji inhibiraju djelovanje katehol-o-metil transferaze
CN113365998A (zh) 用于parp抑制剂的吲哚并七元酰肟类似物
CN114072396A (zh) 作为dna-pk抑制剂的喹啉和噌啉衍生物
RU2006141416A (ru) Пролекарства леводопа, композиции на их основе и их применения
JP2012521429A5 (enExample)
JP2013509429A5 (enExample)
JP2013525444A5 (enExample)
JP2016056183A5 (enExample)
JP2013508279A5 (enExample)
JP2017533221A5 (enExample)
JP2011057693A5 (enExample)
JP2014094963A5 (enExample)
JP2013006854A5 (enExample)
JP2012067115A5 (enExample)
EP4663637A3 (en) Novel deuterium substituted positron emission tomography (pet) imaging agents and their pharmacological application
JP2011246469A5 (enExample)
JP2011523952A5 (enExample)
JP2021530541A5 (enExample)
JP2019520344A5 (enExample)
JP2011046708A5 (enExample)
RU2016136193A (ru) Аминокарбонилкарбаматные соединения
JP2011088926A5 (enExample)
JP2015508068A5 (enExample)
RU2020117569A (ru) Препарат для местного применения для лечения трихофитического онихомикоза
JP2017512211A5 (enExample)